Ono Pharmaceutical Co., Ltd. (TYO:4528)

Ono Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	74,608	92,654	59,328	163,734	143,532	105,025
Depreciation & Amortization	37,255	37,752	26,894	18,140	17,451	17,721
Loss (Gain) From Sale of Assets	-	2,200	7,981	14,885	1,498	3,404
Other Operating Activities	-27,272	-17,305	-45,211	-57,338	-6,655	-34,284
Change in Accounts Receivable	21,234	1,579	7,391	-19,782	-14,513	-15,283
Change in Inventory	17,157	18,962	12,435	-3,420	-2,945	-2,464
Change in Accounts Payable	-13,145	-21,462	18,786	-5,734	18,654	8,177
Change in Other Net Operating Assets	20,518	22,441	-5,145	175	2,588	-20,467
Operating Cash Flow	132,555	136,821	82,459	110,660	159,610	61,829
Operating Cash Flow Growth	29.58%	65.93%	-25.48%	-30.67%	158.15%	-16.42%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-5,366	-6,024	-5,431	-4,020	-5,340	-5,497
Sale of Property, Plant & Equipment	24	21	9	903	6	14
Cash Acquisitions	-	-	-364,816	-	-	-
Sale (Purchase) of Intangibles	1,955	-47,246	-2,559	-16,809	-9,157	-6,780
Investment in Securities	6,516	14,233	236,764	69,290	-84,731	19,969
Other Investing Activities	-151	-844	-752	-1,287	-1,037	-1,668
Investing Cash Flow	2,978	-39,860	-136,785	48,077	-100,259	6,038

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	5,389	-	-	-	-
Long-Term Debt Issued	-	-	150,000	-	-	-
Total Debt Issued	10,713	5,389	150,000	-	-	-
Long-Term Debt Repaid	-	-30,000	-15,000	-	-	-
Total Debt Repaid	-33,230	-30,000	-15,000	-	-	-
Net Debt Issued (Repaid)	-22,517	-24,611	135,000	-	-	-
Repurchase of Common Stock	-1	-1	-1	-50,010	-1	-30,007
Common Dividends Paid	-37,534	-37,532	-37,516	-37,183	-29,742	-27,666
Other Financing Activities	-7	-3,349	-3,184	-2,655	-2,741	-2,564
Financing Cash Flow	-60,059	-65,493	94,299	-89,848	-32,484	-60,237

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	644	1,012	-1,548	1,116	155	436
Miscellaneous Cash Flow Adjustments	-	-	1	-	1	1
Net Cash Flow	76,118	32,480	38,426	70,005	27,023	8,067

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	127,189	130,797	77,028	106,640	154,270	56,332
Free Cash Flow Growth	32.81%	69.80%	-27.77%	-30.87%	173.86%	-15.87%
Free Cash Flow Margin	25.90%	25.36%	15.82%	21.21%	34.50%	15.59%
Free Cash Flow Per Share	270.51	278.31	163.97	222.15	315.90	113.45
Levered Free Cash Flow	116,960	68,574	71,819	79,783	116,639	18,091
Unlevered Free Cash Flow	119,167	69,957	72,725	79,861	116,694	18,143

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	2,228	2,158	1,408	92	74	70
Cash Income Tax Paid	42,568	16,413	44,060	56,431	6,637	34,293
Change in Working Capital	45,764	21,520	33,467	-28,761	3,784	-30,037

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error